Effect of Evacetrapib on the Pharmacokinetics of Pravastatin in Healthy Japanese and Non-Japanese Subjects

Trial Profile

Effect of Evacetrapib on the Pharmacokinetics of Pravastatin in Healthy Japanese and Non-Japanese Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs Evacetrapib (Primary) ; Pravastatin
  • Indications Atherosclerosis; Cardiovascular disorders; Dyslipidaemias
  • Focus Pharmacokinetics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 23 Mar 2015 New source identified and integrated (European Clinical Trials Database record: EudraCT2013-002935-12)
    • 29 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 15 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top